Skip to content

Author

R. Weiskirchen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Antifibrotic therapy in MASLD: fibrosis reversal and HCC prevention

Metabolic dysfunction-associated steatotic liver disease/ metabolic dysfunction-associated steatohepatitis (MASLD/MASH) has become a leading cause of advanced chronic liver disease and hepatocellular carcinoma (HCC). Among all histological features, liver fibrosis is the strongest predictor of liver-related outcomes an...

E. Roeb, R. Weiskirchen · 0 citations
Review Open access Sep 2026

Plant-Derived Protein Hydrolysates and Bioactive Peptides for Restoring Gut Health in Undernutrition: A Scoping Review of Intestinal Barrier Protection, Inflammatory Signaling, and Oxidative Stress Regulation

Background: Childhood undernutrition is associated with intestinal barrier dysfunction, gut dysbiosis, and increased susceptibility to gastrointestinal complications. This review examines whether plant-derived protein hydrolysates and bioactive peptides can influence gut barrier integrity, inflammatory signaling, oxida...

Asad Abbas, M. Afzal, Fahid Nazir et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.